LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

bioMérieux joins EuropaBio: Advancing QC testing for innovative therapies

22/06/2023

NEWS RELEASE

Brussels, 22 June 2023 - EuropaBio is pleased to announce that bioMérieux has joined the association as Corporate Member.

bioMérieux is a family-owned biotechnology company founded in France. Since 1963, it has been at the forefront of ground-breaking advancements in the field of in vitro diagnostics, making significant contributions to improving public health worldwide. bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.

As a world leader in the field of industrial microbiological control, bioMérieux provides diagnostic solutions that detect pathogens and identify microorganisms responsible for contamination at all steps of the manufacturing process as well as within the manufacturing environment in food, pharmaceutical and cosmetic products.

With a partner-first approach to Pharmaceutical Quality Control, the bioMérieux’s experts deliver an integrated offer that easily adapts to facilities, products, and processes, allowing key industry players to provide critical therapies quickly and safely to patients.

EuropaBio Director-General Dr. Claire Skentelbery said “bioMérieux is a valued new member of the EuropaBio community. It reflects Europe’s critical strength and depth behind delivering innovative healthcare. We look forward to their expertise within our work across members within the Healthcare Council and Biomanufacturing Platform.”

bioMérieux (Pharma Quality Control business) Senior VP EMEA Nelly Dumont added “We are very pleased to become a corporate member of EuropaBio's Healthcare Council and Biomanufacturing Platform. Our primary focus is reinforcing the crucial role of quality control in the development and manufacturing of innovative medicine, prioritizing patient safety. Additionally, we aim to establish a robust network with European stakeholders, actively collaborating to strengthen the biotechnology industry in Europe.”

bioMérieux joins EuropaBio: Advancing QC testing for innovative therapies


Download
Share
Francesca Degli Agostini
Francesca Degli Agostini

Related posts

07/07/2025

EuropaBio Position on the Critical Medicines Act


Read more
03/07/2025

Life Sciences Strategy Embraces Biotech for Global Impact


Read more
26/06/2025

EuropaBio AGM 2025: Association Chair, Executive Committee and Board announced


Read more

Important links

  • EuropaBio Position on the Critical Medicines Act
  • Life Sciences Strategy Embraces Biotech for Global Impact

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.